Anne-Marie de Groot
Keine laufenden Positionen mehr
Profil
Anne-Marie de Groot worked as the Head of Clinical Supply Chain Strategic Management at Janssen Pharmaceuticals, Inc. from 2016 to 2019.
She also served as the Chief Ethics & Compliance Officer at Pharming Group NV from 2020 to 2021.
Prior to her professional experience, she obtained an undergraduate degree from Stichting Hogeschool Leiden.
Ehemalige bekannte Positionen von Anne-Marie de Groot
Unternehmen | Position | Ende |
---|---|---|
PHARMING GROUP N.V. | Compliance Officer | 01.05.2021 |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Corporate Officer/Principal | 01.01.2019 |
Ausbildung von Anne-Marie de Groot
Stichting Hogeschool Leiden | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
PHARMING GROUP N.V. | Health Technology |
Private Unternehmen | 1 |
---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |